Bone marrow aplasia associated to the use of ticlopidine

We report a 58 years old male that developed a bone marrow aplasia associated to the use of ticlopidine, prescribed after coronary artery stenting. The patient developed a pneumonia as a complication. He was admitted to the Intermediate Treatment Unit, receiving wide spectrum antimicrobial therapy a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revista medíca de Chile 2002-07, Vol.130 (7), p.798
Hauptverfasser:	Ruiz, Carolina, Monroy, Tatiana, Montaña, Nelson, Lora, Pilar, Lamich, Rubén, Valderrama, Alejandro
Format:	Artikel
Sprache:	spa
Schlagworte:	Bone Marrow Diseases - chemically induced Filgrastim Granulocyte Colony-Stimulating Factor - therapeutic use Humans Leukocyte Count Male Middle Aged Platelet Aggregation Inhibitors - adverse effects Platelet Count Recombinant Proteins Ticlopidine - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We report a 58 years old male that developed a bone marrow aplasia associated to the use of ticlopidine, prescribed after coronary artery stenting. The patient developed a pneumonia as a complication. He was admitted to the Intermediate Treatment Unit, receiving wide spectrum antimicrobial therapy and a granulocyte colony stimulating factor (Neupogen(r)) with favourable response. Ticlodipine is an effective antiplatelet agent, but has serious hematological and other side effects. Its prescription requires a close follow up and search for complications.
ISSN:	0034-9887